Why the FDA approved a controversial Alzheimer's drug
The FDA on Monday approved the first new drug to treat Alzheimer's disease in nearly two decades. Federal health officials said it may help slow the brain-destroying disease's progression, but the approval goes against the agency's independent advisers who said the treatment wasn't effective in clinical trials. Pam Belluck, health reporter for The New York Times, joins Amna Nawaz to discuss.
Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6
Follow us:
Facebook: http://www.pbs.org/newshour
Twitter: http://www.twitter.com/newshour
Instagram: http://www.instagram.com/newshour
Subscribe:
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts
Newsletters: https://www.pbs.org/newshour/subscribe
Видео Why the FDA approved a controversial Alzheimer's drug канала PBS NewsHour
Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6
Follow us:
Facebook: http://www.pbs.org/newshour
Twitter: http://www.twitter.com/newshour
Instagram: http://www.instagram.com/newshour
Subscribe:
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts
Newsletters: https://www.pbs.org/newshour/subscribe
Видео Why the FDA approved a controversial Alzheimer's drug канала PBS NewsHour
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
US approves first new Alzheimer's drug in 20 years - BBC News(original) Man In Nursing Home Reacts To Hearing Music From His EraBiogen reopens following FDA approval of company's Alzheimer drugTen Warning Signs of Alzheimer's DiseaseWATCH LIVE: Austin, Milley testify on U.S. defense budgetBiogen CEO Michel Vounatsos on seeking FDA approval for new Alzheimer's drugFDA's historic approval of Biogen's Alzheimer's drugWhat is Alzheimer's disease? - Ivan Seah Yu JunExperts Respond to the FDA’s Approval of Aducanumab | LiveTalk | Being PatientBiogen CEO on FDA approval for its Alzheimer's drugFDA approves first new Alzheimer's drug in nearly two decades, raising hopes despite skepticismUS FDA approves 1st new Alzheimer’s drug in nearly 20 yearsInside the mind of a master procrastinator | Tim UrbanInside Alzheimer’s diseaseControversy over newly approved Alzheimer's drugFDA authorizes new Alzheimer’s drugFDA approves controversial Biogen Alzheimer's drug | DW NewsAlzheimer’s Is Not Normal Aging — And We Can Cure It | Samuel Cohen | TED TalksJeffrey Cummings, MD, ScD: Where Aducanumab Stands in Alzheimer Clinical PipelineWhy There are Now So Many Shortages (It's Not COVID)